tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ASND Stock Latest News

2 Biotech Stocks With Big FDA Decisions Approaching – Here’s What Analysts Expect
Stock Analysis & Ideas2 Biotech Stocks With Big FDA Decisions Approaching – Here’s What Analysts Expect
9m ago
ASND
CTXR
Ascendis Pharma Outlines Capital Strategy
PremiumCompany Announcements
Ascendis Pharma Outlines Capital Strategy
9d ago
6K
ASND
Ascendis Pharma upgraded to Buy at TD Cowen on improved view of PTH launch
PremiumThe Fly
Ascendis Pharma upgraded to Buy at TD Cowen on improved view of PTH launch
12d ago
ASND
Ascendis Pharma upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Ascendis Pharma upgraded to Buy from Hold at TD Cowen
12d ago
ASND
Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024
PremiumPress Releases
Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024
13d ago
ASND
Ascendis Pharma presents data from Phase 2 ACcomplisH Trial of TransCon CNP
PremiumThe FlyAscendis Pharma presents data from Phase 2 ACcomplisH Trial of TransCon CNP
13d ago
ASND
Ascendis Pharma Updates Corporate Financial Strategy
PremiumCompany Announcements
Ascendis Pharma Updates Corporate Financial Strategy
25d ago
6K
ASND
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PremiumPress Releases
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
1M ago
ASND
Ascendis presents new data/results of Phase 1/2 IL-Believe Trial at ASCO
PremiumThe Fly
Ascendis presents new data/results of Phase 1/2 IL-Believe Trial at ASCO
1M ago
ASND
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
PremiumPress Releases
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
1M ago
ASND
Ascendis Pharma Details Share Capital Strategy
PremiumCompany Announcements
Ascendis Pharma Details Share Capital Strategy
1M ago
6K
ASND
Ascendis Pharma initiated with a Buy at Stifel
PremiumThe Fly
Ascendis Pharma initiated with a Buy at Stifel
1M ago
ASND
Ascendis Pharma to spotlight latest updates for TransCon portfolio at ENDO 2024
PremiumThe FlyAscendis Pharma to spotlight latest updates for TransCon portfolio at ENDO 2024
1M ago
ASND
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
PremiumPress Releases
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
1M ago
ASND
Ascendis Pharma Expands Capital with Warrants and Shares
PremiumCompany Announcements
Ascendis Pharma Expands Capital with Warrants and Shares
2M ago
6K
ASND
Ascendis Pharma price target raised to $140 from $116 at Morgan Stanley
PremiumThe Fly
Ascendis Pharma price target raised to $140 from $116 at Morgan Stanley
2M ago
ASND
Ascendis approval still likely despite PDUFA push out, says BofA
PremiumThe Fly
Ascendis approval still likely despite PDUFA push out, says BofA
2M ago
ASND
FDA Delays Ascendis Pharma’s Drug Review
PremiumCompany Announcements
FDA Delays Ascendis Pharma’s Drug Review
2M ago
6K
ASND
Ascendis says TransCon PTH PDUFA target action date extended three months
PremiumThe Fly
Ascendis says TransCon PTH PDUFA target action date extended three months
2M ago
ASND
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
PremiumPress ReleasesAscendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
2M ago
ASND
Ascendis announces 2-year results from post-hoc analysis of Phase 3 trial
PremiumThe Fly
Ascendis announces 2-year results from post-hoc analysis of Phase 3 trial
2M ago
ASND
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial
PremiumPress Releases
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial
2M ago
ASND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >